Infection Surveillance Solutions Market Poised to Hit USD 1,100 Million by 2027
The global Infection Surveillance Solutions Market is
projected to reach USD 1,100 million by 2027 from USD 577 million in
2022, at a CAGR of 13.8% during the forecast period. Growth in this
market is predominantly driven by the increasing prevalence of
hospital-acquired infections and new Medicare policies, including
non-payment for hospital-acquired conditions. The rising number of
surgeries, the growing geriatric population, the increasing incidence of
chronic diseases, and increasing adoption of antimicrobial stewardship
programs are the other factors driving the growth of this market.
However, data breaches, and lack of skilled analysts are expected to
hamper the growth of this market during the forecast period to a certain
extent.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21857517
Opportunities: Emerging Markets
The
infection surveillance solutions market is expected to experience
significant growth opportunities in countries with emerging economies
such as India, China, Brazil, Russia, and countries in Latin America and
Southeast Asia. This is due to the fact that these regions are home to a
large portion of the world's population, with over half residing in
India and China. Additionally, factors such as public demand for better
quality hospital care, the rise in costs associated with
healthcare-associated infections (HAIs), the emergence of
multi-drug-resistant microorganisms, and government initiatives are
contributing to the growth of the market in these countries.
Challenges: Data security concerns
The
growing reliance on networking and automated technologies (EHR) and the
shifting trend toward healthcare integration and health information
exchanges have helped expand the healthcare privacy and security
landscape. The electronic exchange of patient data offers greater reach
and efficiency in healthcare delivery; however, issues related to data
loss and liability due to broader access are associated with the
electronic exchange of patient data.
Wide patient information
exchanges lead to privacy and security risks and increase the chances of
data breaches. In healthcare, approximately one-third of data breaches
result in medical identity theft, mainly due to a lack of internal
control over patient information, outdated policies, procedures (or
nonadherence to existing ones), and inadequate personnel training. In
the US, the Identity Theft Resource Center reported that the healthcare
industry had the second-largest number of data breaches in 2019, along
with the highest exposure rate per breach.
Prominent players in
the global infection surveillance solutions market include Becton,
Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V.
(Netherlands), Cerner Corporation (US), Baxter International Inc. (US),
GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil
Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna
Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris
Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria),
CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada),
Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US),
Vitalacy Inc. (US), and VIZZIA Technologies (US).
These
companies adopted strategies such as product launches/enhancements,
expansions, agreements, partnerships, collaborations, sales contracts,
investments, joint ventures, and acquisitions to strengthen their market
presence in the infection surveillance solutions market. Recently, new
smaller competitors have emerged from niche markets and are challenging
larger companies by offering lower prices and technological
advancements. To remain competitive, major market players are focusing
on expanding into fast-growing emerging markets and acquiring smaller
companies with favorable technological capabilities or geographic
presence.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21857517
Asia
Pacific region is expected to register the highest CAGR in the
infection surveillance solutions market during the forecast period
The
Asia Pacific market is expected to witness the highest growth from 2022
to 2027. There is a growing need to implement and integrate medical
devices and HCIT solutions in Asia to provide patients with
cost-effective and quality clinical care. As a result, many global HCIT
companies are investing in the Asian market to capitalize on the growing
opportunities. The growing patient volume and the rising need for
accurate and timely tracking and monitoring of diseases will fuel the
growth of the infection surveillance solutions market in Asia Pacific.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment